Private Prescription: Why Patients Choose EverydayMeds
Private Prescription Benefits: Wegovy Versus Mounjaro Access
The NHS pathway for accessing Wegovy versus Mounjaro typically involves GP referral to specialist weight management services, with waiting times often exceeding six months and strict BMI criteria that exclude many suitable candidates. Our private prescription service eliminates these barriers, allowing eligible patients to access either medication through a streamlined 3-minute clinical assessment reviewed by qualified prescribers within 24-48 hours. This approach is particularly valuable for patients who meet clinical criteria but face geographical limitations, work commitments, or simply prefer the convenience of private healthcare.
When comparing Wegovy versus Mounjaro through private prescription, both medications are sourced directly from licensed manufacturers – genuine Novo Nordisk Wegovy and Eli Lilly Mounjaro, identical to NHS supplies. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance whilst offering the flexibility and speed that frustrated NHS patients increasingly seek. The medication quality remains identical; only the access route differs, providing faster initiation and ongoing support through our clinical team.
Wegovy Versus Mounjaro: Pricing and Value Analysis
Wegovy pricing begins at £79.99 for the 0.25mg starter dose (using code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering the first three months of dose escalation. Returning customers benefit from code DOSE25, whilst our Getting Started Bundles and Stay Steady options cater to different treatment phases and patient preferences.
When evaluating Wegovy versus Mounjaro costs privately, both represent significant investments in long-term weight management, but the convenience factor often justifies the expense for patients facing NHS delays. Our transparent pricing includes prescriber fees, medication costs, and next-day cold-chain delivery, with no hidden charges or surprise additions. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering treatment continuity without monthly reordering requirements.
Clinical Evidence: Wegovy Versus Mounjaro Mechanisms
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021), with sustained results demonstrated in the STEP trial programme. The SELECT cardiovascular outcomes study showed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management.
Mounjaro (tirzepatide) operates as a dual GIP/GLP-1 receptor agonist, targeting both glucose-dependent insulinotropic polypeptide and GLP-1 pathways simultaneously. This dual mechanism may offer enhanced glycaemic control and appetite regulation, though direct head-to-head comparisons between Wegovy versus Mounjaro remain limited due to different trial designs and patient populations. Both medications require prescription-only access and must be used alongside a reduced-calorie diet and increased physical activity.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy mimics glucagon-like peptide-1 (GLP-1), a natural hormone released by intestinal cells in response to food intake. This hormone signals the brain's appetite centres, promoting satiety and reducing the drive to eat between meals. The medication slows gastric emptying, meaning food remains in the stomach longer, contributing to prolonged feelings of fullness after smaller portions. Additionally, Wegovy may reduce food cravings and the psychological drive to eat, particularly for high-calorie comfort foods. The once-weekly injection schedule maintains steady blood levels, providing consistent appetite regulation throughout the treatment period.
EverydayMeds Ordering Process: Wegovy Versus Mounjaro
Our streamlined process begins with a comprehensive 3-minute clinical assessment covering medical history, current medications, weight management goals, and contraindication screening. Qualified prescribers review applications within standard 3 working days (or 24 hours with express service), ensuring clinical appropriateness for either Wegovy or Mounjaro based on individual circumstances. Upon approval, medications are dispatched via next-day delivery using temperature-controlled packaging that maintains the required 2-8°C storage conditions. Each delivery includes detailed administration instructions, dose escalation schedules, and access to our ongoing clinical support for treatment optimisation and side effect management.
Storage and Practical Considerations: Wegovy Versus Mounjaro
Both medications require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability (below 30°C) once removed from the fridge, compared to Mounjaro's 21-day limit. The FlexTouch pen delivery system provides accurate dosing with audible click confirmation, whilst the mandatory dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg over 16 weeks) allows gradual tolerability development. Each pen contains four weekly doses, with injection sites rotated between thigh, abdomen, or upper arm to minimise injection site reactions. Proper storage and handling ensure medication efficacy and reduce the risk of treatment interruptions due to temperature excursions.
Private Prescription Advantages: Wegovy Versus Mounjaro Choice
Private prescription access allows patients and prescribers to make individualised decisions about Wegovy versus Mounjaro based on clinical factors, lifestyle preferences, and treatment response rather than formulary restrictions or rationing decisions. This flexibility proves particularly valuable for patients who may benefit from switching treatments due to side effects, efficacy concerns, or changing medical circumstances. Our prescribers can adjust treatment plans, modify dosing schedules, or recommend alternative approaches based on real-world patient feedback rather than rigid protocol adherence.
The private route also enables faster treatment initiation for patients facing time-sensitive health concerns, upcoming procedures, or personal milestones where weight management urgency matters. Unlike NHS services that may require lengthy reassessments or committee approvals for treatment changes, our clinical team can adapt prescriptions promptly whilst maintaining full safety oversight and documentation standards.
Next Steps: Accessing Wegovy Versus Mounjaro Privately
Beginning your weight management journey with either Wegovy or Mounjaro starts with our confidential online assessment, available 24/7 at everydaymeds.co.uk/collections/wegovy. New customers should apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 for optimal pricing. Our clinical team will determine the most appropriate treatment option based on your individual circumstances, medical history, and weight management goals. Both medications are prescription-only medicines requiring ongoing clinical supervision and should be used alongside a reduced-calorie diet and increased physical activity for optimal results. Treatment success depends on consistent use, lifestyle modifications, and regular monitoring through our comprehensive care programme.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
